New Drug Found Safe By FDA Panel For HPV Vaccination

September 9, 2009

US (ChattahBox) – In a move that took a ridiculously long time, an FDA panel has finally confirmed that the vaccine created by GlaxoSmithKline that blocks the HPV virus that causes cervical cancer is safe for young women between 10 and 25.

The vaccine Cervarix, if approved, would compete against the leading market vaccine, Gardasil, and provide another step toward protect women against this devastating disease.

The UK created Cervarix was originally submitted for FDA approval and US sales in 2007, but was blocked pending ‘additional information’.

After two years it has now been recommended by an FDA panel for mass production and sales in the United States. It would secondary option for women who choose to be vaccinated against HPV (a strain of warts virus that has been directly linked to the development of cervical cancer).

There was one side effect that was reported by a small number of patience, and that was a muscle spasm that led to miscarriage. However, researchers aren’t worried:

“This wasn’t a pregnancy trial and it wasn’t meant to be used in pregnancy, it just happened accidentally,” said Dr. Kenneth Noller, one of the researchers on the panel, said.

“I think this could be marketed with the usual caveat that it’s not to be used in pregnancy.”

Source


Comments

Got something to say? **Please Note** - Comments may be edited for clarity or obscenity, and all comments are published at the discretion of ChattahBox.com - Comments are the opinions of the individuals leaving them, and not of ChattahBox.com or its partners. - Please do not spam or submit comments that use copyright materials, hearsay or are based on reports where the supposed fact or quote is not a matter of public knowledge are also not permitted.